|
|
|
|
|
|
|
![Driven by innovation. inspored by patients.]()
|
|
|
|
SIRTEX – THE INNOVATION DRIVER IN Y-90 Come to see SIROS™ at CIRSE!
|
![Driven by innovation. inspored by patients.]()
|
|
|
|
|
![]()
|
|
|
|
|
|
|
|
|
Make plans for CIRSE 2024 with our educational sessions |
|
|
|
|
|
|
Saturday, September 14th |
16:15-17:45
(First floor, Pavilion 5) |
Hands-On Device Training (HDT 3)
Radioembolization: Dosimetry and administration systems (HDT-EMT.PA 1) |
![]() |
|
|
|
|
|
|
|
Sunday, September 15th |
14:30-15:30
Room 1.06
(First floor, Pavilion 4) |
Workshop
EmboCept® S DSM 50 μm for TACE
Meet the Expert |
![]() |
16:15-17:45
(First floor, Pavilion 5) |
Hands-On Device Training (HDT 3)
Radioembolization: Dosimetry and administration systems (HDT-EMT.PA 1) |
![]() |
|
|
|
|
|
|
|
Monday, September 16th |
14:30-15:30
(Auditorium 8) |
SIRTEX SYMPOSIUM @ CIRSE (SY 356)
Use this link to watch the symposium online in the livestream channel |
![]() |
|
|
|
|
|
|
|
Tuesday, September 17th |
14:30-15:30
Room 1.06
(First floor, Pavilion 4) |
Workshop
EmboCept® S DSM 50 μm for TACE
Meet the Expert |
![]() |
|
|
|
|
|
|
|
Connect with us and sign up for the latest news on Sirtex |
|
|
|
|
|
![Subscribe Now]()
|
|
|
|
|
SIR-Spheres Y-90 resin micropsheres
Indications For Use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) or unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. Consult the Instructions for Use (www.Sirtex.com) for a complete listing of indications, contraindications, side effects, warnings, and precautions.
|
|
|
![]()
|
Manufacturer
Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410
Europe, Middle East & Africa Sirtex Medical Europe GmbH Joseph-Schumpeter-Allee 33 53227 Bonn Germany Tel: +49 228 1840 730
EmboCept® S DSM 50 μm
Intended Use / Indication For Use: EmboCept S DSM 50 μm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation. Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.
|
|
|
![]()
|
Manufacturer
Magle Chemoswed AB, Agneslundsvägen 27, SE-212 15 Malmö, Sweden Phone: +46 (0)40 38 33 00, www.maglechemoswed.com Distributed by Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards, NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410 EmboCept is a registered trademark of Magle PharmaCept GmbH.
SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. ©2024 Sirtex Medical Europe GmbH. APM-EMEA-001-09-24
|
|
|
|
|
